Home Search

"life science" - search results

If you're not happy with the results, please do another search

Latest Deals: 23-29 April 2003

0
The AltAssets weekly round up of deals done across the world. This week there were 71 active investors in 31 deals and three exits across nine sectors, compared to 133 active investors in 47 deals and two exits the previous week…

Deals update: European deal flow slows over Easter break

0
Short working weeks and Easter holidays took their toll on European deal flow with the volume of private equity investments falling slightly from the previous week, according to AltAssets deals data.

BML launches E150m life sciences fund

0
Bioscience Managers Limited, (BML), has announced the launch of its fund management business focused on the life sciences sector. The E150m debut fund will be managed by a six strong team and will invest in European mid-stage life science companies.

gamma capital partners holds initial close for Austrian tech VC fund

0
Austrian gamma capital partners has announced an initial close of E10m for its technology venture fund gamma II. The fund, which was launched six months ago, will target high-tech companies in a variety of sectors including life sciences and electronics in Austria and in neighbouring countries.

Deals update: Private equity investment activity remains subdued

0
Private equity investment activity on both sides of the Atlantic remained fairly subdued in the latest week, according to AltAssets deals data. There were 48 deals and one exit in the week ending 8 April, compared with 46 deals and eight exits in the preceding week.

Latest Deals: 01 – 08 April 2003

0
The AltAssets weekly round up of deals done across the world. This week there were 109 active investors in 48 deals and one exit across 14 sectors, compared to 115 active investors in 46 deals and eight exits the previous week…

US biotech specialist MPM announces its largest exit to date with Idenix sale

0
US biotech venture specialist MPM Capital has announced its largest portfolio exit to date with the sale of its interest in Idenix Pharmaceuticals to Novartis Pharma. Novartis will pay shareholders $255m for a controlling share of the company, rising to more than $600m if the firm's drug candidates meet a series of milestones

Trends: March 2003

0
UK ranks top private equity market in Europe for tax and legal environment, European fundraising slows but investment creeps up, exit conditions bleakest for decades, French private equity investment figures up…

North America: March 2003

0
CalPERS discloses private equity data, Onex Corp establishes $1.5bn co-investment fund, Railroad pension plan to invest in private equity, Ohio seeks manager…

Deals Update: Investment activity steady but exits gather pace

0
Private equity investment activity continued at its steady and unremarkable level in the latest week but there was a marked improvement in exit activity, according to the latest AltAssets deals data.

Popular Articles

Blackstone among latest raft of Colorado fire & police pension commitments

0
The $6.8bn-managing Colorado Fire & Police Pension Association has declared $47m of new alternatives fund commitments.

Deal Roundup: Apollo, Sony Pictures said to team up for Paramount bid, Blackstone nears...

0
Apollo Global Management and Sony Pictures are reportedly discussing a joint bid for Paramount Global, after the latter entered exclusive deal talks with independent...

Podcast-turned-venture firm 20VC is back with its largest fund yet

20VC, the venture capital firm that launched off the success of the Twenty Minute VC podcast, is seeking $400m for its third flagship fund.

Healthtech VC launches sophomore fund to back innovators

Early-stage healthtech investor SpringTide Ventures has launched its second flagship fund on $65m to back founders at the “forefront of innovation”.

AE Industrial has pulled in more than $1bn towards Fund III, but its target...

0
Aerospace, defence and government services-focused buyout house AE Industrial Partners has raised more than $1bn towards its third flagship fund, putting it more than halfway to its initial goal.

Europe’s VC fundraising shows signs of holding steady after post-2021 slump

0
European venture capital fundraising has remained resilient at the start 2024 following a two-year slump, with the current run-rate implying more fund closes this year than last, new research from PitchBook shows.

DTCP soars to €1.6bn digital infra fund close, over 8x larger than debut in...

0
DTCP, the infra and growth investment house launched by senior venture capital execs at Deutsche Telekom, has raised about €1.6bn for the final close of its new digital infra fund.

Zoom investor Maven Ventures falls short of Fund IV goal

Consumer tech investor Maven has wrapped up its fourth flagship fund on $60m after reducing its goal for the fundraise amid the choppy capital raising environment.

Evolution Equity scores over $1bn for largest ever cybersecurity fund

New York-based Evolution Equity Partners has hit an oversubscribed $1.1bn for its third flagship fund to back next generation cybersecurity companies "safeguarding the security of the digital world".

Deal Roundup: TPG seals upsized Sayari investment, OEP completes Walki Group trade sale

0
TPG has closed a $235m strategic investment into Sayari, a counterparty and supply chain risk intelligence platform used by government agencies, multinational corporations and...
Technology partner

Get the latest PE News & Research delivered to your inbox every morning

Get the latest PE News & Research delivered to your inbox every morning